US lawmakers urge FDA to investigate US biopharmaceutical firms' trials with China's PLA in Xinjiang over IP theft, ethics, and trial reliability concerns.

US lawmakers, including John Moolenaar, Raja Krishnamoorthi, Anna Eshoo, and Neal Dunn, urge the FDA to investigate US biopharmaceutical firms conducting trials with China's People's Liberation Army in Xinjiang. The Select Committee on the Chinese Communist Party raises concerns about potential intellectual property theft and the ethics of trials in a region with human rights abuses. They also question the trial results' reliability from PLA institutions.

August 25, 2024
5 Articles